Neurology Today in 5

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

This Podcast is being Sponsored by LocumTenens.com

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department.

This Podcast is being Sponsored by LocumTenens.com

In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.

In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.

In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.  

In this week’s podcast, Neurology Today’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.  

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.